Figure (image) Society of Nuclear Medicine and Molecular Imaging Share Print E-Mail Caption 68Ga-PSMA11 PET MIP images at baseline and after 2 cycles of 177Lu-PSMA radioligand therapy in a patients with mCRPC. Credit Andrei Gafita, Matthias Eiber, TUM School of Medicine, Klinikum rechts der Isar, Munich, Germany. Usage Restrictions None Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.